»ó´Ü¿©¹é
±â»ç (Àüü 385°Ç)
[Sub Story] Á¦¹Ì±Û¸³Æ¾, ½ÅÀåÀå¾Ö ȯÀÚ¼­µµ À¯È¿ ÀÓ¼¼Çü ±âÀÚ 2017-02-26 21:19
[Sub Story] A1C¡¤¾àÁ¦Æ¯¼º µû¶ó 1~3Â÷¼±Åà Á¦½Ã ÀÌ»óµ· ±âÀÚ 2017-02-26 21:12
[Late Breaking Studies] µÑ¶ó±Û·çŸÀ̵å, ÁÖ1ȸ Áö¼ÓÇü GLP-1 ¼ö¿ëü ÀÛ¿ëÁ¦ ÀÌ»óµ· ±âÀÚ 2017-02-26 21:11
[Sub Story] ½ÉÇ÷°üÁúȯ ¸·À¸·Á¸é Ç÷´ç¡¤Ç÷¾Ð¡¤ÁöÁú¡¤Ç÷Àü µ¿½Ã°ü¸®ÇØ¾ß ÀÌ»óµ· ±âÀÚ 2017-02-26 21:08
[Sub Story] Ç×´ç´¢º´Á¦ ½ÉÇ÷°ü»ç°Ç ¿¹¹æÈ¿°ú ¾÷µ¥ÀÌÆ® ÀÌ»óµ· ±âÀÚ 2017-02-26 20:57
¶óÀÎ
[Sub Story] ´ç´¢º´ Ç¥ÁØ°ü¸® ±Ç°í¾È Ȳ¼ºÀº ¸ÞµðÄöóÀÌÅÍ 2017-02-26 20:53
[Sub Story] ºñ½ºÅ¸Æ¾°è ÁöÁúÄ¡·áÁ¦, ½ºÅ¸Æ¾ Æ´»õ ³ë¸°´Ù ÀÌ»óµ· ±âÀÚ 2017-02-26 18:03
[Drug Review] Æä³ëÇǺ극ÀÌÆ®Äݸ° Á¤Á¦È­ ¼º°ø¡¤¹ß¸Å ÀÌ»óµ· ±âÀÚ 2017-02-26 17:59
[Sub Story] ¿¡Á¦Æ¼¹Ìºê ½ÉÇ÷°ü ÀÓ»óÇýÅ᤾ÈÀü¼º ÇÕ°Ý ÀÌ»óµ· ±âÀÚ 2017-02-26 17:50
[Sub Story] Ç÷´ç°­ÇÏÁ¦ ¼±ÅúÎÅÍ Ã¼Áß¿µÇâ °í·Á ÀÓ¼¼Çü ±âÀÚ 2017-02-26 16:45
¶óÀÎ
[Sub Story] ¾Ë°í¸®µë ÅëÇÑ ºñ¸¸ ÅëÇÕ°ü¸® Á¦½Ã ÀÓ¼¼Çü ±âÀÚ 2017-02-26 16:32
[Deep in Guideline] Ç÷´çÁ¶Àý ÅëÇÑ 1Â÷Àû ½Å°æº´Áõ ¿¹¹æ °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2017-02-26 15:46
[Cover Story] ½ºÅ¸Æ¾ Æ´»õ °ø·«ÇÏ´Â ºñ½ºÅ¸Æ¾°è ÁöÁúÄ¡·á ÀÌ»óµ· ±âÀÚ 2017-01-13 10:16
[Sub Story] Ç÷´ç°­ÇÏÁ¦·Î ³úÁ¹Áß À§Çè ³·Ãâ ¼ö ÀÖ³ª? ÀÌ»óµ· ±âÀÚ 2016-12-20 14:49
[Late Breaking Studies] ¡°Ä¡¸Å ¸·À» ¼ö ÀÖ´Ù¡± ÀÌ»óµ· ±âÀÚ 2016-12-20 13:47
¶óÀÎ
[Cover Story] 2016³â ÀÇÇлç ÀüȯÁ¡ ¼øȯ±â¡¤³»ºÐºñ Çõ½Å ÀÌ»óµ· ±âÀÚ 2016-12-16 11:57
[Late Breaking Studies] AHA¡¤ASA, Ç÷°ü¼º ÀÎÁöÀå¾Ö ¿¹¹æ¡¤Ä¡·áÀü·« Á¦½Ã ÀÌ»óµ· ±âÀÚ 2016-12-04 22:18
[Conference Report] icdm 2016 ÇÏÀ̶óÀÌÆ® ÀÌ»óµ· ±âÀÚ 2016-11-15 10:48
[Conference Report] EASD 2016 ÇÏÀ̶óÀÌÆ® ÀÓ¼¼Çü ±âÀÚ 2016-11-15 10:18
[Sub Story] ¸ÞÆ®Æ÷¸£¹Î Àå±â°üÂû °á°ú, ´ç´¢º´ ¿¹¹æÈ¿°ú Áö¼Ó ÀÌ»óµ· ±âÀÚ 2016-11-14 19:59
Back to Top